| Gadolinium side effects have recently
| |
| | effect NSF.
|
| been linked to patients undergoing
| |
| | The boxed warning includes the following
|
| magnetic resonance imaging (MRI).
| |
| | warnings and recommendations:
|
| Gadolinium for MRI is used to improve the
| |
| | - Exposure to gadolinium-based contrast
|
| visibility of internal organs and tissue
| |
| | agents (GBCA) increases the risk for
|
| so the radiologist can more easily detect
| |
| | nephrogenic systemic fibrosis (NSF) in
|
| abnormalities. A population-based study
| |
| | patients with acute or chronic severe
|
| led by Dr. Aneet Deo revealed that
| |
| | renal insufficiency, or acute renal
|
| patients with end stage renal disease
| |
| | insufficiency due to the hepato-renal
|
| (ESRD) were at an increased risk for
| |
| | syndrome or in the perioperative liver
|
| gadolinium side effects. Nephrogenic
| |
| | transplantation period.
|
| systemic fibrosis (NSF) was found in ESRD
| |
| | - NSF is a debilitating and sometimes
|
| patients after gadolinium exposure.
| |
| | fatal disease affecting the skin, muscle,
|
| The study analyzed data from 467 patients
| |
| | and internal organs.
|
| on kidney dialysis due to ESRD. MRI with
| |
| | - Avoid use of gadolinium unless the
|
| gadolinium was reported in 87 patients
| |
| | diagnostic information is essential and
|
| who underwent 123 radiological studies,
| |
| | regular MRI studies are not available.
|
| the most common being MRI of the abdomen
| |
| | - All patients should be screened for
|
| and pelvis. The study was the first to
| |
| | renal dysfunction (kidney problems) by
|
| strongly associate gadolinium side
| |
| | obtaining a history and if necessary
|
| effects like NSF with dialysis patients.
| |
| | laboratory test.
|
| The researchers documented 4.3 cases of
| |
| | - When administering a gadolinium
|
| NSF per 1000 patient-years. From these
| |
| | contrast agent, do not exceed the
|
| initial studies it appears that only
| |
| | recommended dose outlined in the product
|
| patients with end stage renal disease
| |
| | labeling. Prior to any readministration
|
| (kidney disease) seem to be at risk of
| |
| | of gadolinium there needs to be
|
| developing the debilitating skin disorder
| |
| | sufficient time for elimination of the
|
| nephrogenic systemic fibrosis (NSF).
| |
| | gadolinium.
|
| Nephrogenic systemic fibrosis is a
| |
| | The FDA is currently considering other
|
| systemic disorder that is potentially
| |
| | risk management options in response to
|
| fatal. NSF is characterized by thickening
| |
| | the discovery of gadolinium side effects
|
| and tightening of the skin. It was first
| |
| | in patients after undergoing MRI studies.
|
| observed in 1997 when it was referred to
| |
| | Patients are strongly urged to contact
|
| as nephrogenic fibrosing dermopathy
| |
| | their doctor immediately after receiving
|
| (NFD). Although the exact cause of NSF is
| |
| | a gadolinium MRI if they have any of the
|
| unknown, recent studies have shown a link
| |
| | following symptoms that may indicate the
|
| between NSF and patients with kidney
| |
| | development of NSF:
|
| problems following gadolinium MRI
| |
| | Skin and eyes
|
| exposure.
| |
| | - Swelling, hardening and tightening of
|
| The gadolinium side effect NSF usually
| |
| | your skin
|
| starts in the lower extremities although
| |
| | - Reddened or darkened patches on the
|
| it can also develop in the diaphragm,
| |
| | skin
|
| muscles in the thigh and lower abdomen,
| |
| | - Burning or itching of your skin
|
| and lungs. As patients develop skin
| |
| | - Yellow raised spots on the whites of
|
| thickening they can suffer from decreased
| |
| | your eyes
|
| joint mobility resulting from the
| |
| | Bones and muscles
|
| inability to bend and extend joints. NSF
| |
| | - Stiffness in your joints; problems
|
| has been reported following
| |
| | moving or straightening arms, hands,
|
| administration of all five of the FDA
| |
| | legs, or feet
|
| approved gadolinium contrast agents:
| |
| | - Pain deep in your hip bones or ribs
|
| Magnevist, MultiHance, Omniscan,
| |
| | - Muscles weakness
|
| OptiMARK, and ProHance.
| |
| | The reported time between a patient
|
| In response to the association of NSF and
| |
| | undergoing an MRI with gadolinium and
|
| gadolinium MRI the Food and Drug
| |
| | diagnosis of NSF varies widely among
|
| Administration (FDA) has issued a
| |
| | patients. It can range from days to
|
| healthcare alert including new warnings
| |
| | several months. Patients suffering from
|
| regarding nephrogenic systemic fibrosis.
| |
| | NSF can die from complications related to
|
| The FDA's new boxed warning is for
| |
| | the disease.
|
| patients at risk for the gadolinium side
| |
| |
|
